Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02895711 · ClinicalTrials.gov registry record

Radiation Dose of Pediatric Patients During Ureteroscopy

A clinical trial, sponsored by University of Pittsburgh.

Completed
Registry status
126
Enrollment target

NCT02895711: Completed study, sponsored by University of Pittsburgh.

NCT02895711 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02895711 has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
126 participants
Enrollment target

Study Summary

The purpose of this study is to quantify the radiation exposure from diagnostic testing and surgical treatment during routine endourologic procedures for symptomatic urolithiasis.

Primary Outcome

To record the effective radiation dose to the patient during endourologic procedures to treat urolithiasis

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2010-09
Est. Completion 2020-12
University of Pittsburgh

1,238 total trials

What the finished NCT02895711 record still lists

NCT02895711 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02895711 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02895711 about?

NCT02895711 is a clinical study titled "Radiation Dose of Pediatric Patients During Ureteroscopy". The purpose of this study is to quantify the radiation exposure from diagnostic testing and surgical treatment during routine endourologic procedures for symptomatic urolithiasis.

What is the current status of trial NCT02895711?

This trial is currently completed. The enrollment target is 126 participants. The study started on 2010-09. Estimated completion is 2020-12.

Who is sponsoring clinical trial NCT02895711?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02895711, the US trial registry maintained by the National Library of Medicine. NCT02895711 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.